| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Mar 24 | GANX Gain Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 4.06 | 6,085 | 24.71 k | 21,140 |
| 26 Mar 24 | GANX Gain Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 637 | 0.00 | 27,225 |
| 26 Mar 24 | GANX Gain Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 825 | 0.00 | 26,588 |
| 26 Mar 24 | GANX Gain Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 18,750 | 0.00 | 25,763 |
| 26 Mar 24 | GANX Gain Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 637 | 0.00 | 6,376 |
| 26 Mar 24 | GANX Gain Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 825 | 0.00 | 8,250 |
| 26 Mar 24 | GANX Gain Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 18,750 | 0.00 | 56,250 |
| 21 Mar 24 | GANX Gain Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.37 | 370,000 | 1.62 mm | 370,000 |
| 21 Dec 23 | GANX Gain Therapeutics | Common Stock | Sell | Dispose S | No | No | 2.46 | 206 | 506.76 | 5,286 |
| 20 Dec 23 | GANX Gain Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 637 | 0.00 | 5,492 |
